Back to search

Article

Lysin (K)-Specific Demethylase 1 Inhibition Enhances Proteasome Inhibitor Response and Overcomes Drug Resistance in Multiple Myeloma

2023-05-18

Abstract excerpt

<h4>Background: </h4> Multiple myeloma (MM) is an incurable plasma cell malignancy, accounting for approximately 1% of all cancers. Despite recent advances in the treatment of MM, due to the introduction of proteasome inhibitors (PIs) such as bortezomib (BTZ) and carfilzomib (CFZ), relapses and disease progression remain common. Therefore, a major challenge is the development of novel therapeutic approaches to ove...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2c0bc77d-8a33-5301-8708-f24a4770e8b1
DOI
10.21203/rs.3.rs-2938292/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lysin (K)-Specific Demethylase 1 Inhibition Enhances Proteasome Inhibitor Response and Overcomes Drug Resistance in Multiple MyelomaDOI 10.21203/rs.3.rs-2938292/v1
Select a neighboring publication to make it the new centre.